Gingrich; Diane E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gingrich; Diane E..The latest application filed is for "imidazo[4,5-b]pyridine derivatives as alk and jak modulators for the treatment of proliferative disorders".

Company Profile

0.19.15

Gingrich; Diane E. - Downingtown PA
Gingrich; Diane E. - Downington PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Imidazo[4,5-b]pyridine derivatives as ALK and JAK modulators for the treatment of proliferative disorders Grant 9,238,656 - Breslin , et al. January 19, 2	2016-01-19
Imidazo[4,5-b]pyridine Derivatives as ALK and JAK Modulators for the Treatment of Proliferative Disorders App 20140350011 - Breslin; Henry J. ; et al.	2014-11-27
Preparation and uses of 1,2,4-triazolo [1,5a] pyridine derivatives Grant 8,633,173 - Curry , et al. January 21, 2	2014-01-21
Preparation and Uses of 1,2,4-Triazolo [1,5a] Pyridine Derivatives App 20130296312 - Curry; Matthew A. ; et al.	2013-11-07
Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-MET inhibitors Grant 8,552,186 - Ahmed , et al. October 8, 2	2013-10-08
Preparation and uses of 1,2,4-triazolo [1,5a] pyridine derivatives Grant 8,501,936 - Curry , et al. August 6, 2	2013-08-06
Pyrrolotriazines as ALK and JAK2 inhibitors Grant 8,471,005 - Breslin , et al. June 25, 2	2013-06-25
Fused pyrrolocarbazoles Grant 8,383,813 - Becknell , et al. February 26, 2	2013-02-26
Substituted bicyclic pyrimidines Grant 8,354,414 - Bacon , et al. January 15, 2	2013-01-15
Fused Bicyclic Derivatives of 2,4-Diaminopyrimidine as ALK and c-MET Inhibitors App 20120165519 - Ahmed; Gulzar ; et al.	2012-06-28
Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-Met inhibitors Grant 8,148,391 - Ahmed , et al. April 3, 2	2012-04-03
Pyrrolotriazines As Alk And Jak2 Inhibitors App 20120028919 - Breslin; Henry J. ; et al.	2012-02-02
Novel Fused Pyrrolocarbazoles App 20120004253 - Becknell; Nadine C. ; et al.	2012-01-05
Substituted Bicyclic Pyrimidines App 20110053920 - Bacon; Edward R. ; et al.	2011-03-03
Substituted pyrazolo[3,4-d]pyrimidines Grant 7,851,468 - Bacon , et al. December 14, 2	2010-12-14
Preparation and Uses of 1,2,4-Triazolo [1,5a] Pyridine Derivatives App 20100311693 - Curry; Matthew A. ; et al.	2010-12-09
Novel Fused Pyrrolocarbazoles App 20100152196 - Becknell; Nadine C. ; et al.	2010-06-17
Fused pyrrolocarbazoles Grant 7,671,064 - Hudkins , et al. March 2, 2	2010-03-02
FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND c-MET INHIBITORS App 20090221555 - Ahmed; Gulzar ; et al.	2009-09-03
Substituted pyrazolopyrimidines App 20070281949 - Bacon; Edward R. ; et al.	2007-12-06
Selected fused pyrrolocarbazoles Grant 7,230,026 - Gingrich , et al. June 12, 2	2007-06-12
Fused pyrrolocarbazoles Grant 7,169,802 - Hudkins , et al. January 30, 2	2007-01-30
Novel fused pyrrolocarbazoles App 20060247294 - Becknell; Nadine C. ; et al.	2006-11-02
Selected fused pyrrolocarbazoles Grant 7,115,613 - Gingrich , et al. October 3, 2	2006-10-03
Selected fused pyrrolocarbazoles App 20060135590 - Gingrich; Diane E. ; et al.	2006-06-22
Novel fused pyrrolocarbazoles App 20050143442 - Hudkins, Robert L. ; et al.	2005-06-30
Selected fused pyrrolocarbazoles App 20030203957 - Gingrich, Diane E. ; et al.	2003-10-30
Selected fused pyrrolocarbazoles Grant 6,630,500 - Gingrich , et al. October 7, 2	2003-10-07
Selected fused pyrrolocarbazoles App 20020061920 - Gingrich, Diane E. ; et al.	2002-05-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.